Respiratory Diseases

Importance and Measures

Mortality
Number of deaths due to lung diseases (2001)................................................................. 231,54536
Number of deaths, influenza and pneumonia combined (2003)........................................... 64,8472
Cause of death rank, influenza and pneumonia combined (2003)........................................ 7th2
   
Prevalence
Americans 18 or over with an asthma attack in past 12 months (2003).............................. 13,623,00037
Americans under 18 with an asthma attack in past 12 months (2003)................................ 3,975,00038
   
Incidence
Annual number of cases of the common cold in the U.S. (est)........................................... >1 billion39
Annual number of pneumonia cases (1996)...................................................................... 4,800,00040
   
Cost
Total cost of lung diseases (2005 est.)......................................................................... $139.6 billion3
Direct medical costs of lung diseases (2005 est.).......................................................... $80.7 billion3
Total approximate cost of upper respiratory infections (annual)........................................ $40 billion41
Total cost of asthma (2004).......................................................................................... $27.6 billion36
Direct medical costs of asthma (2004).......................................................................... $11.5 billion36
Measures

The NHQR tracks several quality measures for prevention and treatment of this broad category of illnesses that includes influenza, pneumonia, asthma, upper respiratory infection, and tuberculosis. The four core report measures highlighted in this section are:

Return to Contents

Prevention: Pneumococcal Vaccination Treatment: Receipt and Completion of Substance Abuse Care